Pheon Therapeutics
Antibody Drug Conjugate company developing a pipeline of monotherapies for targets and/or with payloads
Pheon Therapeutics has raised €71M across 1 funding round from 4 investors, most recently a Series A round in Sep 2022. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.pheontx.com ↗
Total raised
€71M
€71,092,525
Funding rounds
1
Investors
4
distinct backers
Active since
2022-09
latest 2022-09
Funding by year
EUR raised per yearPheon Therapeutics — funding by year — interactive chart.
Data table
| Pheon Therapeutics — funding by year | |
|---|---|
| 2022 | €71M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-28 | Series A | €71M | Atlas Venture,Brandon Capital,Forbion,Research Corporation Technologies | View deal → |
Related news
- Pheon Therapeutics Raises $68M in Series A Financingfinsmes.com · 2022-09
Similar companies
same sector or countryGlobal coverage: FundingData